Brief report| Volume 37, ISSUE 6, P417-419, March 15, 1995

Neurochemistry and paroxetine response in major depression

      This paper is only available as a PDF. To read, Please Download here.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. American Psychiatric Association, Washington DC1987
        • Celada P
        • Dolera M
        • Alvarez E
        • et al.
        Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients.
        in: Relationship to clinical outcome. J Affect Dis. 25. 1992: 243-250
        • Dechant KL
        • Clissold SP
        Paroxetine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
        Drugs. 1991; 41: 225-253
        • Goodnick P
        Pharmacokinetic optimisation of therapy with newer antidepressants.
        Clin Pharmacokinet. 1994; 27: 307-330
        • Kumar AM
        • Kumar M
        • Krishnaprasad D
        • et al.
        A modified HPLC technique for simultaneous measurement of 5hydroxytryptamine and 5hydroxindoleacefic acid in cerebrospinal fluid, platelets, and plasma.
        Life Sci. 1990; 47: 1751-1759
        • Lu R-B
        • Ko H-C
        • Huang C-C
        • et al.
        The relationship of monoamine systems to fluoxetine responsiveness in depressed patients.
        Biol Psychiatry. 1992; 31: 98A
        • Muck-Seler D
        • Jakovljevic M
        • Deanovic Z
        Effect of antidepressant treatment on platelet 5HT content and relation to therapeutic outcome in unipolar depressive patients.
        J Affect Dis. 1991; 23: 157-164
        • Salzman C
        • Jimerson D
        • Vasile R
        • et al.
        Response to SSRI antidepressants correlates with reduction in plasma HVA: Pilot study.
        Biol Psychiatry. 1993; 34: 569-571
        • Stahl SM
        • Woo DJ
        • Mefford IN
        • et al.
        Hyperserotonemia and platelet serotonin content and release in schizophrenia and affective disorders.
        Am J Psychiatry. 1983; 140: 26-30